Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Creditriskmonitor Com (CRMZ) Liabilities and Shareholders Equity (2016 - 2025)

Creditriskmonitor Com (CRMZ) has 15 years of Liabilities and Shareholders Equity data on record, last reported at $25.9 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 0.53% year-over-year to $25.9 million; the TTM value through Sep 2025 reached $101.3 million, up 1.8%, while the annual FY2024 figure was $24.9 million, 3.49% up from the prior year.
  • Liabilities and Shareholders Equity reached $25.9 million in Q3 2025 per CRMZ's latest filing, down from $26.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $26.1 million in Q2 2025 and bottomed at $18.5 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $22.8 million, with a median of $22.6 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: increased 16.09% in 2021, then fell 0.05% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $20.4 million in 2021, then increased by 10.0% to $22.5 million in 2022, then increased by 7.14% to $24.1 million in 2023, then grew by 3.49% to $24.9 million in 2024, then grew by 3.83% to $25.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $25.9 million in Q3 2025, $26.1 million in Q2 2025, and $24.4 million in Q1 2025.